The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis

BACKGROUND: The responses of cancer patients to immune checkpoint inhibitors (ICIs) vary in success. CD8+ tumor infiltrating lymphocytes (TILs) play a key role in killing tumor cells. This study aims to evaluate the prognostic role of CD8+ TILs in cancer patients treated with ICIs. METHODS: We syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Feng, Li, Caichen, Cai, Xiuyu, Xie, Zhanhong, Zhou, Liquan, Cheng, Bo, Zhong, Ran, Xiong, Shan, Li, Jianfu, Chen, Zhuxing, Yu, Ziwen, He, Jianxing, Liang, Wenhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452798/
https://www.ncbi.nlm.nih.gov/pubmed/34585125
http://dx.doi.org/10.1016/j.eclinm.2021.101134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452798/
https://www.ncbi.nlm.nih.gov/pubmed/34585125
http://dx.doi.org/10.1016/j.eclinm.2021.101134

Ejemplares similares